[go: up one dir, main page]

UY30112A1 - Nuevos benzotiazoles sustitidos por heteroarilo - Google Patents

Nuevos benzotiazoles sustitidos por heteroarilo

Info

Publication number
UY30112A1
UY30112A1 UY30112A UY30112A UY30112A1 UY 30112 A1 UY30112 A1 UY 30112A1 UY 30112 A UY30112 A UY 30112A UY 30112 A UY30112 A UY 30112A UY 30112 A1 UY30112 A1 UY 30112A1
Authority
UY
Uruguay
Prior art keywords
relates
alzheimer
benzotiazols
heteroarilo
suspected
Prior art date
Application number
UY30112A
Other languages
English (en)
Inventor
David Pyring
Can Slivo
Ylva Gravenfors
Peter Strom
Catrin Jonasson
Sohn Daniel
Nordvall Gunnar
Wensbo David-Edwards
Malmstrom Jonas
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38309497&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30112(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY30112A1 publication Critical patent/UY30112A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invencinn se refiere a nuevos derivados de benzotiazol sustituidos por heteroarilo, precursores de los mismos y usos terapeuticos para dichos compuestos, que presentan la fnrmula estructural (I): y sales farmaccuticamente aceptables de los mismos, composiciones y mctodos de uso. Ademrs, la invencinn se refiere a nuevos derivados de benzotiazol sustituidos por heteroarilo que son adecuados para la formación de imrgenes de depnsitos amiloides en pacientes vivos, sus composiciones, mctodos de uso procesos para prparar dichos compuestos. Mrs específicamente, la prsente invencinn se refiere a un mctodo de formacinn de imrgenes de depnsitos amiloides en el cerebro in vivo para permitir un diagnnstico en vida de la enfermedad de Alzheimer, ase como tambicn medir la eficacia clenica de los agentes terapcuticos de la enfermedad de Alzheimer.
UY30112A 2006-01-27 2007-01-26 Nuevos benzotiazoles sustitidos por heteroarilo UY30112A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76265406P 2006-01-27 2006-01-27

Publications (1)

Publication Number Publication Date
UY30112A1 true UY30112A1 (es) 2007-08-31

Family

ID=38309497

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30112A UY30112A1 (es) 2006-01-27 2007-01-26 Nuevos benzotiazoles sustitidos por heteroarilo

Country Status (20)

Country Link
US (2) US8163928B2 (es)
EP (1) EP1981883A4 (es)
JP (1) JP5289061B2 (es)
KR (1) KR101406248B1 (es)
CN (1) CN101410393B (es)
AR (1) AR059178A1 (es)
AU (1) AU2007207904C1 (es)
BR (1) BRPI0707283A2 (es)
CA (1) CA2640213A1 (es)
EC (1) ECSP088645A (es)
IL (1) IL192876A0 (es)
NO (1) NO20083394L (es)
NZ (1) NZ569667A (es)
RU (1) RU2448106C2 (es)
SA (1) SA07280009B1 (es)
TW (2) TW201018678A (es)
UA (1) UA95267C2 (es)
UY (1) UY30112A1 (es)
WO (1) WO2007086800A1 (es)
ZA (1) ZA200806075B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201018678A (en) 2006-01-27 2010-05-16 Astrazeneca Ab Novel heteroaryl substituted benzothiazoles
TW200813035A (en) 2006-06-19 2008-03-16 Astrazeneca Ab Novel heteroaryl substituted benzoxazoles
TW200901998A (en) 2007-03-06 2009-01-16 Astrazeneca Ab Novel 2-heteroaryl substituted benzothiophenes and benzofuranes
JP5603855B2 (ja) 2008-04-04 2014-10-08 アビッド レディオファーマシューティカルズ、インク． 神経変成疾患の放射性薬剤による画像化
JP2011524864A (ja) 2008-05-30 2011-09-08 メルク・シャープ・エンド・ドーム・コーポレイション 新規な置換されたアザベンゾオキサゾール
US8193363B2 (en) 2008-08-29 2012-06-05 Astrazeneca Ab Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits
US20110212031A1 (en) * 2008-10-31 2011-09-01 Cyrille Sur Novel substituted azabenzoxazoles
WO2011045415A2 (en) 2009-10-15 2011-04-21 Guerbet New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
JP6069661B2 (ja) * 2010-06-24 2017-02-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 種々のアミロイドβペプチドアロフォームレベルの調節における組成物及びその使用
US9272055B2 (en) * 2011-04-21 2016-03-01 The Regents Of The University Of California Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
WO2013040183A1 (en) * 2011-09-16 2013-03-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Beta-amyloid imaging agents, methods of manufacture, and methods of use thereof
CN102558091B (zh) * 2011-12-22 2014-10-08 合肥工业大学 一种苯并噻唑类衍生物及其用途
CN102659772B (zh) * 2012-05-03 2015-02-11 北京师范大学 一种与Aβ斑块有亲和力的2-芳基苯并杂环化合物及其制备方法和应用
JP5422782B1 (ja) 2012-12-21 2014-02-19 独立行政法人放射線医学総合研究所 脳内に蓄積したタウタンパク質をイメージングするための新規化合物
EP2968296B1 (en) 2013-03-12 2020-09-02 The Regents of the University of California Gamma-secretase modulators
TWI652014B (zh) 2013-09-13 2019-03-01 美商艾佛艾姆希公司 雜環取代之雙環唑殺蟲劑
WO2015051188A1 (en) * 2013-10-02 2015-04-09 Washington University Heterocyclic molecules for biomedical imaging and therapeutic applications
US20170216252A1 (en) * 2014-07-11 2017-08-03 Simon Fraser University Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods
WO2016010092A1 (ja) 2014-07-16 2016-01-21 国立研究開発法人科学技術振興機構 ベンゾチアゾール化合物及びこれを含有する医薬
EP3212633B1 (en) 2014-10-31 2019-12-04 The General Hospital Corporation Potent gamma-secretase modulators
BR112017011661A2 (pt) * 2014-12-02 2018-03-06 Bayer Cropscience Aktiengesellschaft compostos bicíclicos como agentes de controle de pragas.
US10292970B2 (en) 2014-12-02 2019-05-21 Bayer Pharma Aktiengesellschaft Heteroaryl-substituted imidazo[1,2-A]pyridines and their use
CN107743486B (zh) * 2015-03-12 2021-04-09 Fmc公司 杂环取代的二环唑杀有害生物剂
AU2016315648B2 (en) 2015-08-28 2021-04-01 Chdi Foundation, Inc. Probes for imaging huntingtin protein
GB201617339D0 (en) 2016-10-12 2016-11-23 Lytix Biopharma As Therapeutic compounds
WO2019028164A1 (en) * 2017-08-02 2019-02-07 Spinogenix, Inc. BENZOTHIAZOLES AND RELATED COMPOUNDS
TW201946624A (zh) 2018-05-09 2019-12-16 新旭生技股份有限公司 雜芳基化合物及其用途
CA3100235A1 (en) * 2018-05-16 2019-11-21 Emory University Styrylbenzothiazole derivatives and uses in imaging
PL3917521T3 (pl) * 2019-01-31 2025-10-20 Spinogenix, Inc. Postacie stałe promotora spinogenezy
GB201914989D0 (en) * 2019-10-16 2019-11-27 Karin & Sten Mortstedt Cbd Solutions Ab Selective ligands for TAU Aggregates
TWI759962B (zh) 2019-11-13 2022-04-01 香港商新旭生技股份有限公司 用於降解tau蛋白聚集體的化合物及其用途
KR102682408B1 (ko) * 2021-05-12 2024-07-05 에이치케이이노엔 주식회사 신규한 벤조티아졸 유도체, 이의 제조방법 및 이의 간질환 예방 또는 치료 용도
CN114478431B (zh) * 2022-03-09 2024-07-02 台州学院 一种双取代苯并噻吩类钾离子通道激动剂的制备方法
CN114380731B (zh) * 2022-03-09 2024-07-02 台州学院 一种kcnq钾离子通道激动剂、药物组合物及其应用
CN120303267A (zh) 2022-11-03 2025-07-11 森托尼克思有限公司 针对tau聚集体的选择性配体
WO2025202955A1 (en) 2024-03-28 2025-10-02 Pi Industries Ltd. Fused bicyclic compounds and their use as pest control agents

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
GB8305245D0 (en) 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds
US4556411A (en) * 1984-12-07 1985-12-03 Fmc Corporation Benzothiazole derivatives for plant growth and development modification
JPS6394248A (ja) 1986-10-08 1988-04-25 Canon Inc 電子写真感光体
CA2034309C (en) * 1990-01-22 1997-04-01 Takashi Iwaki Mesomorphic compound, liquid crystal composition containing same, liquid crystal device using same and display apparatus
EP0735821A4 (en) 1993-12-21 1998-04-01 Lilly Co Eli METHODS FOR TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH AMYLO DOGEN PEPTIDES
US5518713A (en) * 1995-02-13 1996-05-21 3V Inc. Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them
JPH11116476A (ja) 1997-10-16 1999-04-27 Sankyo Co Ltd 縮合複素環化合物
EP2264018B1 (en) * 2000-08-24 2015-02-11 University of Pittsburgh - Of the Commonwealth System of Higher Education Thioflavin derivatives for use in the diagnosis of Alzheimer's disease
US7045539B2 (en) 2000-12-22 2006-05-16 Astrazeneca Ab Therapeutic benzoxazole compounds
US6596731B2 (en) 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
ES2274973T3 (es) 2001-04-23 2007-06-01 The Trustees Of The University Of Pennsylvania Inhibidores de la agregacion de placas amiloides y agentes de obtencion de imagenes diagnosticas.
US7622479B2 (en) * 2001-11-26 2009-11-24 Takeda Pharmaceutical Company Limited Bicyclic derivative, its production and use
GB0130305D0 (en) 2001-12-19 2002-02-06 Amersham Plc Compounds for imaging alzheimers disease
WO2003106439A1 (ja) 2002-06-12 2003-12-24 株式会社ビーエフ研究所 アミロイド蓄積性疾患の画像診断プローブ化合物、老人斑／びまん性老人斑染色用化合物、ならびにアミロイド蓄積性疾患の治療薬
TW200401194A (en) 2002-07-11 2004-01-16 Advanced Micro Devices Inc Method and apparatus for determining a processor state without interrupting processor operation
AU2003258022A1 (en) 2002-08-02 2004-02-23 Genesoft Pharmaceuticals, Inc. Biaryl compounds having anti-infective activity
JP2004250411A (ja) 2003-02-21 2004-09-09 Bf Kenkyusho:Kk アミロイドβ蓄積性疾患の診断プローブおよび治療用化合物
CA2438032C (en) 2003-03-14 2013-05-07 University Of Pittsburgh Benzothiazole derivative compounds, compositions and uses
JPWO2004087641A1 (ja) 2003-03-31 2006-06-29 第一製薬株式会社 ヒドラゾン誘導体
US7329682B2 (en) * 2003-04-03 2008-02-12 Ewha University-Industry Collaboration Foundation Method for inhibiting 5-lipoxygenase using a benzoxazole derivative
PL1636217T3 (pl) * 2003-05-13 2009-02-27 Hoffmann La Roche 1-Imidazobenzotiazole jako ligandy receptora adenozynowego
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
WO2006125324A1 (en) 2005-05-27 2006-11-30 Queen's University At Kingston Treatment of protein folding disorders
WO2007033080A2 (en) 2005-09-12 2007-03-22 Emory University Alzheimer's disease imaging agents
EP1937260A2 (en) 2005-09-16 2008-07-02 University of Pittsburgh In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein
ES2379987T3 (es) 2005-10-11 2012-05-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compuestos de benzofurano marcados isotópicamente como radiotrazadores para proteínas amiloidógenas
ATE533485T1 (de) * 2005-10-31 2011-12-15 Merck Sharp & Dohme Cetp-inhibitoren
WO2007063946A1 (ja) 2005-11-30 2007-06-07 Fujifilm Ri Pharma Co., Ltd. アミロイドの凝集及び／又は沈着に起因する疾患の診断薬及び治療薬
TW201018678A (en) 2006-01-27 2010-05-16 Astrazeneca Ab Novel heteroaryl substituted benzothiazoles
WO2008118122A2 (en) * 2006-05-08 2008-10-02 Molecular Neuroimaging, Llc Compounds and amyloid probes thereof for therapeutic and imaging uses
TW200813035A (en) * 2006-06-19 2008-03-16 Astrazeneca Ab Novel heteroaryl substituted benzoxazoles
CN101641354A (zh) 2007-01-22 2010-02-03 阿斯利康(瑞典)有限公司 杂芳基取代的新咪唑并[1，2-a]吡啶衍生物

Also Published As

Publication number Publication date
RU2008130965A (ru) 2010-03-10
EP1981883A1 (en) 2008-10-22
IL192876A0 (en) 2009-02-11
US20090028787A1 (en) 2009-01-29
WO2007086800A1 (en) 2007-08-02
NO20083394L (no) 2008-10-02
AR059178A1 (es) 2008-03-12
ECSP088645A (es) 2008-08-29
TW201018678A (en) 2010-05-16
AU2007207904B2 (en) 2011-03-10
KR101406248B1 (ko) 2014-06-19
KR20080090542A (ko) 2008-10-08
CN101410393B (zh) 2012-01-25
AU2007207904C1 (en) 2011-10-13
EP1981883A4 (en) 2010-10-06
NZ569667A (en) 2011-09-30
JP2009528271A (ja) 2009-08-06
US20120207679A1 (en) 2012-08-16
ZA200806075B (en) 2012-12-27
JP5289061B2 (ja) 2013-09-11
TW200736252A (en) 2007-10-01
SA07280009B1 (ar) 2011-07-20
CA2640213A1 (en) 2007-08-02
BRPI0707283A2 (pt) 2011-04-26
US8163928B2 (en) 2012-04-24
UA95267C2 (en) 2011-07-25
CN101410393A (zh) 2009-04-15
US8957215B2 (en) 2015-02-17
AU2007207904A1 (en) 2007-08-02
RU2448106C2 (ru) 2012-04-20

Similar Documents

Publication Publication Date Title
UY30112A1 (es) Nuevos benzotiazoles sustitidos por heteroarilo
UY30419A1 (es) Nuevos benzoxazoles heteroaril sustituidos
WO2009155017A3 (en) Novel substituted azabenzoxazoles
ECSP099641A (es) Nuevos benzotiofenos y benzofuranos sustituidos en la posición 2 con heteroarilo 709
AR114029A2 (es) Compuestos adecuados como precursores de compuestos que son útiles para obtener imágenes de depósitos amiloides, usos y procesos
MX2016016384A (es) Pirrolo[2,3-c]piridinas como agentes de formacion de imagenes para ovillos neurofibrilares.
CL2012000708A1 (es) Compuestos derivados de imidazopiridina o imidazopirimidina, inhibidores de pde10a; proceso de preparacion de dichos compuestos; composiciones farmaceuticas; y su uso para el tratamiento terapeutico y/o preventivo de trastornos psicoticos, esquizofrenia, enfermedad de alzheimer, tumores solidos, entre otras enfermedades.
AR079641A1 (es) Compuestos para el diagnostico por imagenes de la muerte de las celulas por apotosis
CR11690A (es) Pirazolo (3,4-b) piridinas como inhibidores de raf
MX2009007487A (es) Derivados de imidazo[1,2-a]piridina substituidos de heteroarilo novedosos.
CU20100062A7 (es) Derivados de pirrolo [2,3-d] pirimidina como inhibidores de proteínas quinasas b
CY1116692T1 (el) Πυρρολοπυριδινες ως αναστολεις κινασης
ECSP10010510A (es) Compuestos del inhibidor de raf y métodos de uso de los mismos
ECSP12011857A (es) Compuestos de dióxido de iminotiadiazina como inhibidores de bace, composiciones, y su uso
CO6290683A2 (es) Compuestos de pirido imidazolinas heterociclicas y sus composiciones como inhibidores de c-met
AR070395A1 (es) Derivados de 4,5-dihidro-oxazol-2-il- amina
GT200500242A (es) Procesos para la preparaciòn de 2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolinas sustituidas
BRPI0617151B8 (pt) composto, multímero, composto vetorizado, complexo do referido composto, bem como composições farmacêutica, farmacêutica lipídica e de diagnóstico para imagiologia por ressonância magnética e processo para a preparação de um complexo metálico
ECSP088587A (es) Compuestos de piperidina 3,5-sustituida como inhibidores de renina
UA113186C2 (xx) Макроциклічні інгібітори lrrk2 кінази
UY30377A1 (es) Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa
ECSP099722A (es) Compuestos de pirido [2, 3-d] pirimidina-7-ona como inhibidores de pi3k-alfa para el tratamiento del cáncer
WO2010051196A8 (en) Novel substituted azabenzoxazoles
MX2009009113A (es) Nuevos indoles 2-heteroaril sustituidos 695.
DOP2024000096A (es) Derivados de naftiridinona para el tratamiento de una enfermedad o un trastorno

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170526